Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07443254 · ClinicalTrials.gov registry record · Phase 1
Prospective IR-led Sedation Feasibility
A Phase 1 study of Anesthesia and Sedation and Analgesia, sponsored by CAMC Health System.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT07443254 is a Phase 1 study of Anesthesia and Sedation and Analgesia that is actively recruiting participants, run by CAMC Health System. The registered enrollment target is 40 participants, below the 109,410-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07443254, a Phase 1 study of Anesthesia and Sedation and Analgesia, is actively recruiting participants, sponsored by CAMC Health System.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study wants to see if some interventional radiology (IR) procedures can be done without using general anesthesia. General anesthesia needs a lot of staff and equipment. It can also cause side effects. There are not enough anesthesia providers, which makes it harder to use for every procedure. The researchers will test deep sedation with ketamine instead. They will start with 20 patients. If it works well and is safe, they may include up to 40 patients. Patients will be asked to join the study before their procedure. The anesthesia team will be told ahead of time and will be ready to help if needed. The IR team will give the deep sedation and follow all safety rules. The main goal is to finish the procedure without stopping early or switching to general anesthesia. The study will call this successful if fewer than 10% of cases fail. The researchers will also look at patient pain, patient satisfaction, any side effects, and how long recovery takes.
Conditions Studied
Interventions
- DRUG Midazolam
- DRUG ketamine
- DRUG Fentanyl (IV)
Study Locations (1)
West Virginia
- CAMC Memorial - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-03-02 |
| Est. Completion | 2027-04-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07443254
The ClinicalTrials.gov registry entry for NCT07443254 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 109,410-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The listed sponsor is CAMC Health System, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Anesthesia appearing as the primary indexed condition, and to 3 interventions - of which Midazolam is the first listed.
NCT07443254 reports 1 study location spanning 1 distinct geographic area - top geographies include West Virginia.
Frequently Asked Questions
What is clinical trial NCT07443254 about?
NCT07443254 is a clinical study titled "Prospective IR-led Sedation Feasibility". This study wants to see if some interventional radiology (IR) procedures can be done without using general anesthesia. General anesthesia needs a lot of staff and equipment. It can also cause side effects. There are not enough anesthesia providers, which makes it harder to use for every procedure. ...
What is the current status of trial NCT07443254?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2026-03-02. Estimated completion is 2027-04-03.
What conditions does trial NCT07443254 study?
This clinical trial studies the following conditions: Anesthesia, Sedation and Analgesia, Interventional Radiology.
What interventions are being tested in trial NCT07443254?
The interventions under investigation include: Midazolam (DRUG), ketamine (DRUG), Fentanyl (IV) (DRUG).
Who is sponsoring clinical trial NCT07443254?
This trial is sponsored by CAMC Health System, which has 28 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07443254 being conducted?
This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anesthesia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Comparison of Procedural Sedation in TEE
COMPLETED · Phase 1
-
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
RECRUITING
-
Total Intravenous Versus Inhalational Anesthesia- A Geriatric Anesthesia Study
RECRUITING · Phase 4
-
Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration
RECRUITING · Phase 3
-
The Million Anesthesia Cases Study (MACS) - a Cohort Study of Preoperative Fasting and Perioperative Outcomes
RECRUITING
-
Oral Methadone in Cardiac Surgery
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.